ArticleThoracic cancer2024

Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Ayami Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.